Can Deriphylline (xanthine derivative) tablets cause toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Deriphylline Toxicity

Yes, deriphylline tablets can cause toxicity, particularly affecting the cardiovascular, central nervous system, and gastrointestinal systems, similar to other xanthine derivatives like theophylline.

Mechanism and Risk Factors

Deriphylline is a xanthine derivative similar to theophylline, which has well-documented toxicity profiles. As a methylxanthine, it can cause significant adverse effects when blood levels exceed the therapeutic range 1.

Risk factors that increase the likelihood of deriphylline toxicity include:

  • High daily doses (>10 mg/kg/day in adults)
  • Drug interactions (particularly with erythromycin and other medications that inhibit cytochrome P450 enzymes) 2
  • Hepatic or renal insufficiency
  • Advanced age
  • Concurrent illness

Clinical Manifestations of Toxicity

Deriphylline toxicity can manifest with various symptoms affecting multiple organ systems:

Cardiovascular Effects

  • Tachycardia
  • Tachyarrhythmias (supraventricular tachycardia)
  • Hypotension in severe cases

Central Nervous System Effects

  • Headache
  • Seizures (particularly in severe toxicity)
  • Central nervous system stimulation
  • Dizziness
  • Insomnia

Gastrointestinal Effects

  • Nausea
  • Vomiting
  • Gastric upset
  • Aggravation of ulcer or reflux

Metabolic Effects

  • Hyperglycemia
  • Hypokalemia
  • Metabolic acidosis in severe cases

Monitoring and Prevention

To prevent deriphylline toxicity:

  1. Start with appropriate dosing (10 mg/kg/day initially in adults, with maximum of 16 mg/kg/day) 1
  2. Monitor for early signs of toxicity (nausea, tachycardia, headache, insomnia)
  3. Avoid concomitant administration with drugs known to interact with xanthines
  4. Consider therapeutic drug monitoring in high-risk patients
  5. Adjust dosage in patients with hepatic or renal insufficiency

Management of Toxicity

If deriphylline toxicity is suspected:

  1. Discontinue the medication immediately
  2. Provide supportive care:
    • Fluid and electrolyte management
    • Antiemetics for nausea/vomiting
    • Seizure control if needed
  3. In severe cases:
    • Gastric lavage or emesis (if recent ingestion)
    • Activated charcoal administration
    • Multiple-dose activated charcoal may enhance elimination 3
    • Charcoal hemoperfusion in life-threatening cases

Special Considerations

  • Pediatric patients: Children may be more susceptible to toxicity and require careful dosing and monitoring 1
  • Elderly patients: Lower doses are recommended due to decreased clearance
  • Patients with hepatic impairment: At higher risk for toxicity due to reduced metabolism 4
  • Drug interactions: Monitor closely when used with medications that inhibit cytochrome P450 enzymes 2

Conclusion

Deriphylline, like other xanthine derivatives, has a narrow therapeutic window and can cause significant toxicity. The risk increases with higher doses, drug interactions, and in patients with impaired drug clearance. Careful dosing, monitoring, and awareness of early toxicity signs are essential for safe use of this medication.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Theophylline toxicity due to drug interaction.

The Journal of emergency medicine, 1989

Research

Theophylline toxicity.

The Journal of allergy and clinical immunology, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.